The prognosis and treatment consideration for non-small cell lung carcinoma patients with tumor size of >2.0–3.0 cm and visceral pleural invasion: a SEER-based study
Xirui Lin, Haijie Xu, Jianrong Chen, Jiaying Wu, Jiong Lin, Hansheng Wu · 2024
Read The prognosis and treatment consideration for non-small cell lung carcinoma patients with tumor size of >2.0–3.0 cm and visceral pleural invasion: a SEER-based study by Xirui Lin, Haijie Xu, Jianrong Chen, Jiaying Wu, Jiong Lin, Hansheng Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11651767.txt.
Description
Xirui Lin and co-authors use a large United States cancer registry in this 2024 study to settle a staging question in early lung cancer. Tumors two to three centimeters wide that invade the lung's inner lining may be worse than their stage suggests. The team pulled 10,452 patients with node-free tumors of two to five centimeters, diagnosed from 2010 to 2019, and compared survival across stage groups and treatments.
Patients in the two-to-three band with invasion fared worse than both nearby stage groups at five years. Chemotherapy after surgery lifted their outlook to match a higher stage group that also got it, and one lower group gained clearly from it. The authors back post-surgery chemotherapy for these patients.
Catalog record
| CREATOR | Xirui Lin, Haijie Xu, Jianrong Chen, Jiaying Wu, Jiong Lin, Hansheng Wu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |